Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DESIGN CONTROLS CITED IN HALF OF ALL QUALITY SYSTEM WARNING LETTERS IN 2005, BUT FDA SAYS FIRMS HAVE MADE GREAT PROGRESS IN PAST 10 YEARS

This article was originally published in The Silver Sheet

Executive Summary

NEARLY TEN YEARS AFTER FDA REQUIRED DESIGN CONTROLS by way of the Quality System Regulation, statistics show that some manufacturers still are not meeting the requirements, with half of all quality system warning letters issued in 2005 containing some sort of design control violation. However, experts agree that companies’ attitudes toward design controls have come a long way since the regulation was published in 1996. CDRH Quality Systems Expert Kim Trautman says the agency still believes strongly in the flexibility built into the design control requirements, but notes that this flexibility also can lead to trouble for firms that don’t play by the rules. "We’re giving manufacturers a rope," she says. "They can either use that rope for good ... or they can hang themselves with that rope when they don’t use it wisely"... 2006 COULD BRING SOME IMPORTANT CHANGES to the device industry, including stricter postmarket surveillance and an intensified focus on risk management, experts predict...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel